Article
Recombinant adeno‐associated virus production evaluation in Chinese hamster ovary cells
30 Oct 2023
Abstract excerpt
Abstract The gene therapy field has advanced in recent years with five recombinant adeno‐associated virus (rAAV) based products winning Food and Drug Administration (FDA) approval. As the number of therapeutic applications and overall production demands for rAAV increase, it is valuable to evaluate rAAV production in different production cells. Chinese hamster ovary (CHO) cells have been a robust host for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
